The executive said the decision to take the company "90 days at a time" was inspired by a "radical experiment" he helped implement at Genentech in 2016 before becoming CEO of the biotech company ...

She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

Roche has filled the open CEO position at Genentech with Alexander Hardy, a veteran of the subsidiary. The position has been open since previous CEO Bill Anderson left to head up Roche’s ...

CVRM product development global head and senior vice-president Manu Chakravarthy will be the centre's site head.

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé will retire in December, when he will be succeeded by Genentech CEO Alexander Hardy. The transition comes with BioMarin in the early stages of ...

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and inclusion (D&I) page undergoes construction. “The page that is under ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus. | Roche and ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Roche will be the first to join Harvard's Enterprise Research Campus in Allston, taking a suite in the first phase of the ...